CLAGE Sequential With Flu-Bu Conditioning for Refractory Acute Leukemia

NCT03882203 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Refractory Hematologic Cancer
Allogeneic Stem Cell Transplantation

Interventions

DRUG: CLAGE-FluBu

Sponsor

Shanghai Jiao Tong University School of Medicine